Three receptors, three jobs, all pulling in the same direction
Glucagon agonism acts directly on hepatocytes to reduce liver fat accumulation, regulate metabolic function, and is thought to resolve inflammation and improve fibrosis functions that GLP-1 agonism alone does not accomplish
Symptoms vary among people, may come and go, and can change over time
Deeper understanding of these mechanisms may revolutionize the therapeutics of obesity, diabetes, and related disorders through interventions that harmonize sensory experience with metabolic needs
Eating enough protein, avoiding nutrient deficiencies, managing stress, and working with a healthcare provider can help reduce hair shedding without stopping Ozempic or other GLP-1 medications